JXR Buys Back 7.30 Million Shares for HK$15.02 Million; Cumulative Repurchases Reach 119.59 Million Under 2025 Mandate

Bulletin Express
06/23

Jinxin Fertility Group Limited (“JXR”) disclosed a Next Day Return showing the on-market repurchase of 7.30 million ordinary shares on 23 June 2026.

• Transaction details – Volume: 7,303,500 shares – Price range: HK$2.03–HK$2.08 per share – Volume-weighted average price: HK$2.06 – Aggregate consideration: HK$15.02 million

• Outstanding buy-backs awaiting cancellation – Total shares repurchased but not yet cancelled between 27 March and 23 June 2026 amount to 79.92 million, equivalent to approximately 2.96 % of the company’s 2.71 billion issued shares. – The latest purchase will also be cancelled, leaving treasury shares at zero.

• Position under existing mandate – Shareholders granted a mandate on 26 June 2025 allowing the company to buy back up to 274.47 million shares. – After the latest transaction, 119.59 million shares have been repurchased, utilising 4.36 % of issued shares as at the mandate date. – A 30-day moratorium on new share issues or sales of treasury stock is in force until 23 July 2026.

• Capital structure – Issued share capital stands at 2.71 billion shares; no new shares have been issued over the period covered by the return.

All repurchases were executed on the Hong Kong Stock Exchange in accordance with Main Board Rule 10.06, and the company confirms no changes to the explanatory statement filed on 4 June 2025.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10